《仿制药发展动态》2013年第一季度
The latest edition of Movers and Shakers is now available reviewing developments in the US generic industry during the first quarter of 2013. Highlights include:[*]47 companies from 12 countries received a total of 121 final ANDA approvals.
[*]The FDA posted information on the first Paragraph IV patent challenges to a single new active ingredient, down from three during the previous quarter.·
[*]Numerous deals in the increasingly global generic drug industry, with many deals continuing to be
motivated by the need to expand into emerging markets or strengthen existing international operations.
11111 好东西，谢谢楼主分享！
页:
[1]